Our data suggested that PKM2 played a significant role in promoting migration potential and invasiveness of prostate cancer cells, in part, through ERK1/2 pathway activation becausePKM2 interacted with ERK1/2 and colocalized with ERK1/2 in prostate cancer cells. This evidence concerns the gene MAPK3 and prostate carcinoma.